The European Union (EU) policy for healthcare requires the establishment of a system of European Reference Networks, union-wide information databases, and registries for rare diseases (RDs) based on shared criteria. In pursuing its goals, the ‘Building Consensus and Synergies for the EU Registration of RD Patients in Europe’ (EPIRARE) project convened a meeting with experts of the competent health authorities to discuss the role of national institutional RD patient registries in supporting EU patient registration and the room for international cooperation. With this aim, this paper comparatively analyses the current situation of national institutional RD registries in the EU.</p
Rare diseases are diseases with a particularly low prevalence. The specificities of rare diseases - ...
International audienceBACKGROUND:Although rare disease patients make up approximately 6-8% of all pa...
© 2020, Advanced Scientific Research. All rights reserved. Rare diseases are defined as diseases wit...
Rare disease (RD) registries are important platforms that facilitate communication between health ca...
The EPIRARE project[1] aims to build consensus and synergies for the development of an EU platform f...
Registries as strategic instruments to improve knowledge in the field of Rare Diseases [1,2]. Intero...
Rare diseases (RD) patient registries are powerful instruments that help develop clinical research, ...
Rare diseases (RD) patient registries are powerful instruments that help develop clinical research, ...
Rare diseases are defined, as any condition or disease having a low prevalence in the United States ...
In 2009 the European Commission asked the Member States to develop a strategy to improve the care of...
BACKGROUND: The European Union acknowledges the relevance of registries as key instruments for devel...
The development of a national Rare Diseases (RD) registry in Spain was launched in 2012 with the pro...
In summary, National Institute of Rare Diseases Research and Regional Health Departments of Spain ar...
The aim for this thesis is to investigate the value of registries for regulatory decision-making in ...
Rare diseases are diseases with a particularly low prevalence. The specificities of rare diseases - ...
International audienceBACKGROUND:Although rare disease patients make up approximately 6-8% of all pa...
© 2020, Advanced Scientific Research. All rights reserved. Rare diseases are defined as diseases wit...
Rare disease (RD) registries are important platforms that facilitate communication between health ca...
The EPIRARE project[1] aims to build consensus and synergies for the development of an EU platform f...
Registries as strategic instruments to improve knowledge in the field of Rare Diseases [1,2]. Intero...
Rare diseases (RD) patient registries are powerful instruments that help develop clinical research, ...
Rare diseases (RD) patient registries are powerful instruments that help develop clinical research, ...
Rare diseases are defined, as any condition or disease having a low prevalence in the United States ...
In 2009 the European Commission asked the Member States to develop a strategy to improve the care of...
BACKGROUND: The European Union acknowledges the relevance of registries as key instruments for devel...
The development of a national Rare Diseases (RD) registry in Spain was launched in 2012 with the pro...
In summary, National Institute of Rare Diseases Research and Regional Health Departments of Spain ar...
The aim for this thesis is to investigate the value of registries for regulatory decision-making in ...
Rare diseases are diseases with a particularly low prevalence. The specificities of rare diseases - ...
International audienceBACKGROUND:Although rare disease patients make up approximately 6-8% of all pa...
© 2020, Advanced Scientific Research. All rights reserved. Rare diseases are defined as diseases wit...